Why Brain Models Fail —What Pharma Needs:>95% of CNS drugs fail in late-stage trials: Animals lack predictive powerPharma needs human-relevant tools: Reduce cost, time, and attritionWhat Drives Demand:$2M–$4M and 2–3 years per IND study~$1.2B cost per failed neurological asset5–7-years with no translational insights The First Commercial‘Brain-on-Chip Interface’Drug Discovery Platform Organoids for Drug Discovery Modeling Neural Circuits We are integrating electrophysiology platforms with advanced cell culture and AI/ML-Driven Analysis Methods to Model the Brain. Stay tuned, there is more to come… If you are interested in learning more, please reach out via email or submit an inquiry through our contact submission.
